Sleep Disordered Breathing (SDB) Completed Phase 1 / 2 Trials for Liraglutide (DB06655)

Also known as: Sleep Disordered Breathing

IndicationStatusPhase
DBCOND0068417 (Sleep Disordered Breathing (SDB))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01832532A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 WeeksTreatment